Home > Boards > US Listed > Biotechs > Sorrento Therapeutics, Inc. (SRNE)

SRNE. If the treatment is a cure. I

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
EquityMonster83 Member Profile
 
Followed By 69
Posts 4,952
Boards Moderated 7
Alias Born 10/31/08
160x600 placeholder
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/30/2020 5:22:59 PM
SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST... GlobeNewswire Inc. - 9/30/2020 9:26:45 AM
Sorrento Therapeutics and ViralClear Enter Into Agreement to Explore Combination Antibody Plus Antiviral Therapy Against COVI... GlobeNewswire Inc. - 9/30/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2020 6:08:09 AM
Sorrento Releases Preclinical Data for STI-1499 (COVI-Guard™) and STI-2020 (COVI-AMG™), Potent Neutralizing Antibodies Ag... GlobeNewswire Inc. - 9/28/2020 11:59:34 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/28/2020 4:16:30 PM
Sorrento Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) In Reduction of OsteoArthritis (OA) Knee Pain GlobeNewswire Inc. - 9/28/2020 9:00:10 AM
Sorrento Therapeutics Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) Epidural in Cancer Patients with R... GlobeNewswire Inc. - 9/22/2020 2:30:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2020 6:04:36 AM
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 (COVI-GUARD) Neutralizing Antibody in C... GlobeNewswire Inc. - 9/16/2020 9:30:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 6:04:19 AM
Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) Platf... GlobeNewswire Inc. - 9/14/2020 6:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/2/2020 9:10:45 AM
Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-E... GlobeNewswire Inc. - 9/2/2020 9:00:10 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 8/21/2020 5:27:30 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/21/2020 4:49:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2020 4:56:30 PM
Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Star... GlobeNewswire Inc. - 8/20/2020 4:05:10 PM
Sorrento Announces FDA IND Filing Today for COVI-GUARD Neutralizing and High Potency Antibody Against SARS-CoV-2 GlobeNewswire Inc. - 8/19/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2020 4:48:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 7:45:15 PM
Sorrento to Take Action Against Hindenburg Research for Statements Believed Intended to Manipulate Stock Price GlobeNewswire Inc. - 8/12/2020 7:51:28 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/10/2020 6:29:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 6:28:13 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/4/2020 4:35:24 PM
EquityMonster83   Friday, 05/15/20 11:05:28 PM
Re: None
Post # of 6397 
SRNE. If the treatment is a cure. I honestly could see the share price hitting $70-$100 based on their small 1 billion market cap right now. Shares currently $7.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences